日本ケミファ(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|---|---|---|
東証STD | 医薬品 | 4539/E00957 | NIPPON CHEMIPHAR CO., LTD. |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|---|---|---|---|---|---|---|---|---|
2020/05/22 | 日証協 | 33,223株 | +3.41% | 1,396株 | +132.67% | 71,510株 | +1.13% | 5,110株 | +88.91% |
2020/05/15 | 日証協 | 32,127株 | +1.9% | 600株 | +20% | 70,714株 | -0.56% | 2,705株 | -20.46% |
2020/05/08 | 日証協 | 31,527株 | -14.16% | 500株 | -94.95% | 71,114株 | -5.77% | 3,401株 | -53.69% |
2020/05/01 | 日証協 | 36,727株 | +35.39% | 9,900株 | +450% | 75,471株 | +2.03% | 7,344株 | +136.83% |
2020/04/24 | 日証協 | 27,127株 | +3.43% | 1,800株 | -73.13% | 73,971株 | +1.09% | 3,101株 | +10.71% |
2020/04/17 | 日証協 | 26,227株 | +15.03% | 6,700株 | -71.37% | 73,171株 | +5.37% | 2,801株 | -78.95% |
2020/04/10 | 日証協 | 22,800株 | +14% | 23,400株 | -14.76% | 69,441株 | +0.3% | 13,305株 | -21.6% |
2020/04/03 | 日証協 | 20,000株 | +8.11% | 27,452株 | +2041.34% | 69,233株 | +2.13% | 16,970株 | +1195.42% |
2020/03/27 | 日証協 | 18,500株 | -35.64% | 1,282株 | -91.4% | 67,787株 | -16.12% | 1,310株 | -93.66% |
2020/03/19 | 日証協 | 28,745株 | -3.4% | 14,900株 | -3.33% | 80,810株 | +19.95% | 20,675株 | +218.03% |
2020/03/13 | 日証協 | 29,758株 | +3.16% | 15,413株 | +62.55% | 67,367株 | -1.6% | 6,501株 | -26.18% |
2020/03/06 | 日証協 | 28,847株 | +5.49% | 9,482株 | +125.65% | 68,464株 | +63.1% | 8,807株 | -77.9% |
2020/02/28 | 日証協 | 27,347株 | -2.54% | 4,202株 | -74.53% | 41,977株 | +8.66% | 39,849株 | +696.66% |
2020/02/21 | 日証協 | 28,059株 | +10.65% | 16,500株 | +103.7% | 38,630株 | +10.03% | 5,002株 | +354.73% |
2020/02/14 | 日証協 | 25,359株 | -3.43% | 8,100株 | -19% | 35,108株 | -3.31% | 1,100株 | -88.15% |
2020/02/07 | 日証協 | 26,259株 | +7.8% | 10,000株 | +75.44% | 36,308株 | -21.45% | 9,283株 | +299.27% |
2020/01/31 | 日証協 | 24,359株 | +0.41% | 5,700株 | -6.56% | 46,225株 | -0.16% | 2,325株 | -37.26% |
2020/01/24 | 日証協 | 24,259株 | +6.59% | 6,100株 | -71.36% | 46,300株 | +15.72% | 3,706株 | -38.28% |
2020/01/17 | 日証協 | 22,759株 | +6.05% | 21,300株 | +280.22% | 40,010株 | -1.96% | 6,005株 | +275.31% |
※株式分割は考慮していませんのでご注意ください。